Skip to main content
. 2020 Apr 29;9(4):42. doi: 10.1038/s41389-020-0226-z

Fig. 6. c-Myc is the downstream effector of ACSL4-mediated HCC progression.

Fig. 6

a Western blotting showed the expression levels of ACSL4, c-Myc, FBW7, SKP2 after treatment Huh7-shACSL4 cells with FBW7 or SKP2 siRNA. b, c CCK-8 and colony-formation assays for indicated Huh7 cells were evaluated. d Western blotting showed the suppression efficiency after treatment Bel-7402-pcDNA-ACSL4 and PLC/PRF5-pcDNA-ACSL4 cells with c-Myc siRNA or a specific c-Myc inhibitor 10058-F4 (20 μM). e, f CCK-8 and colony-formation assays for indicated Bel-7402 and PLC/PRF5 cells were evaluated. Data are presented as the mean ± SD (n = 3 biological replicates). ***p < 0.001. The data were analyzed using Student’s t-test.